Brian S Skrainka, MD Pediatrics - Pediatric Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 11014 S Gum St, Jenks, OK 74037 Phone: 314-914-1112 |
Dr. Lisa E Hart, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 715 W Main St Ste S, Jenks, OK 74037 Phone: 918-745-0501 Fax: 918-747-9778 |
Dr. Kathleen Shepherd Koljack, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 E Main St, Jenks, OK 74037 Phone: 918-298-2264 Fax: 918-298-0923 |
Melinda Dandridge, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 410 E Main St, Jenks, OK 74037 Phone: 918-298-5437 Fax: 918-298-5438 |
News Archive
NPR's "Shots" blog examines the debate over Option B+, a strategy to prevent mother-to-child HIV transmission that "aims to put every pregnant woman with HIV on triple-drug treatment and keep her on it for the rest of her life - even if the virus has not yet damaged her immune system to the point where she needs medications to preserve her own health."
"A declaration to be made at next week's world food summit in Rome will not mention a target to eradicate hunger by 2025 nor a commitment to spend $44 billion a year in agricultural aid, according to a final draft," Reuters reports (Aloisi, 11/12).
In making your pro-longevity resolutions, like drinking more red wine and maintaining a vibrant social network, here's one you likely forgot: dialing down your mitochondria. It turns out that slowing the engines of these tiny cellular factories could extend your life-an observation relevant not only to aging research but to our understanding of how cells communicate with each another.
A comprehensive programme providing older people at risk of dementia with healthy eating guidance, exercise, brain training, and management of metabolic and vascular risk factors appears to slow down cognitive decline, according to the first ever randomised controlled trial of its kind, published in The Lancet.
AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnifeĀ® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.
› Verified 1 days ago